On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Monitoring Pulse Post-Stroke Can Help Patients Detect Potential Atrial Fibrillation
New research suggests that most patients who have suffered a stroke can be taught to reliably detect the first signs of atrial fibrillation by measuring their peripheral pulse at the radial artery.
FDA Approves Zorvolex for the Treatment of Osteoarthritis Pain
August 25th 2014Clinicians who treat patients suffering with osteoarthritis pain have a new low-dose nonsteroidal anti-inflammatory drug (NSAID) option at their disposal. Zorvolex (diclofenac) was developed to meet prevailing FDA recommendations regarding NSAID dosing and treatment duration.
Post-Surgery Atrial Fibrillation in Hospitalized Patients Is Associated with Increased Stroke Risk
Research suggests that patients who develop seemingly temporary cases of atrial fibrillation immediately after most types of surgery are dramatically more likely to suffer subsequent strokes.
Pennsylvania Implements New Guidelines for Treating Pain in the Emergency Department
The guidelines were developed as part of a multi-part plan to curb misuse, abuse, and diversion of opioid medication by preventing opioid medications from being inappropriately prescribed in the emergency department, and by reducing the overuse of emergency departments for pain relief.
Promising Developments in Fecal Microbiota Transplantation
Researchers have made several impressive advances in gastrointestinal medicine in recent years, including the use of fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infection. Following the success of that approach, researchers have been evaluating FMT for the treatment of other conditions, with one team recently conducting the first randomized controlled trial of FMT to treat inflammatory bowel disease (IBD).
Combination Hydrocodone Products Moving to Schedule II in October
August 22nd 2014Rescheduling hydrocodone combination products to the more-restrictive schedule II will impact clinicians and patients suffering with chronic pain, but will it have the desired effect on the misuse and abuse of these products?
Apremilast and the Future of Psoriatic Arthritis Treatment
August 21st 2014When it was approved by the FDA in March 2014, apremilast became the first oral medication approved for the treatment of psoriatic arthritis (PsA). Data from clinical trials showed it to be an effective option for patients, with a safer side effect profile than currently used PsA treatments.